PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.9850
-0.0200 (-1.99%)
Apr 28, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 680.48 million as of April 28, 2026. Its market cap has decreased by -7.51% in one year.
Market Cap
680.48M
Enterprise Value
669.41M
Revenue
139.49M
Ranking
n/a
PE Ratio
70.00
Stock Price
0.99
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 680.48M, an increase of 1,956.63%. That is a compound annual growth rate of 11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 690.84M | -18.70% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 6.37B |
| 4DMedical | 2.81B |
| Anteris Technologies Global | 739.23M |
| Aroa Biosurgery | 183.33M |
| EMVision Medical Devices | 167.29M |
| Lumos Diagnostics Holdings | 152.24M |
| SomnoMed | 136.93M |
| Epiminder | 129.81M |